Senior Commercial Advisor @ (September 2018 - December 2022)
President and CEO @ R-Pharm US (January 2014 - January 2018)
SVP CV and MET and President US Diabetes @ (January 2012 - October 2013)
President, Emerging Markets and Global Access @ (January 2010 - January 2012)
SVP, Neuroscience Disease Area Leader, Global Market Access and Pricing @ (January 2008 - January 2010)
SVP, Neuroscience Sales and Marketing @ (January 2007 - January 2008)
VP, Plavix Marketing @ (January 2006 - January 2007)
SVP, Sales and Marketing @ (January 2004 - January 2006)
VP, Abilify Marketing @ (January 2001 - January 2004)
VP, Marketing and Sales @ HeliosHealth (January 2000 - January 2001)
Marketing, Market Access, Managed Care, Sales @ (January 1989 - January 2000)
Marketing Internship @ (October 1987 - June 1988)
Marketing Intern @ Pan Am (May 1985 - August 1985)
Mark Pavao Education
The Wharton School
MBA
The University of North Carolina at Chapel Hill
BA
St. Mark's School
Southborough (MA)
St. Paul's School
Sao Paulo (Brazil)
Markham College
Lima (Peru)
Mark Pavao Skills
Biopharmaceuticals
Cardiology
Clinical Development
Clinical Research
Commercialization
Diabetes
Endocrinology
Executive Management
Global Marketing
Healthcare
Managed Care
Market Access
Neuroscience
Oncology
Pharmaceutical Industry
Pharmaceutical Sales
Pharmaceutics
Product Launch
Sales Effectiveness
Strategy
Team Leadership
Vision Development
Sales
Leadership
Customer Service
Global Leadership
Marketing
Microsoft Excel
Social Media
Mark Pavao Summary
Mark Pavao, based in United States, is currently a Managing Partner at Biotech Value Advisors LLC. Mark Pavao brings experience from previous roles at Coya Therapeutics, Inc., Perosphere, Medical Knowledge Group and Biohaven. Mark Pavao holds a MBA @ The Wharton School. With a robust skill set that includes Biopharmaceuticals, Cardiology, Clinical Development, Clinical Research, Commercialization and more. Mark Pavao has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Mark Pavao?
Find contact details for 700 million professionals.